Skip to main content
21 January 2021
Last updated:
Thursday 21 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Wolfgang Baiker becomes CEO at Adrenomed

Wednesday 6 January 2021
Company
Adrenomed AG
Appointee Name
Wolfgang 
Baiker
Country

Germany

Wolfgang Baiker, a venture partner with Wellington Partners, has been appointed chief executive of Adrenomed AG which is developing a product for septic shock. Dr Baiker is a former CEO of Boehringer Ingelheim USA and before that, held a number of positions at the German company including head of global development and head of global manufacturing.

Dr Baiker obtained a medical degree from Ludwigs-Maximilians-Universität Munich and a PhD from the University of Ulm, both in Germany. He earned a master of business administration from Pace University in New York City, US.

Adrenomed announced the appointment on 4 January 2021.

Copyright 2021 Evernow Publishing Ltd

 

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

T-knife appoints Thomas Soloway as chief executive
Thursday January 21 2021
Domainex makes two executive appointments
Thursday January 21 2021
Richard Francis named CEO of Purespring
Tuesday January 19 2021
Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.